Vera Therapeutics Q2 EPS $(0.33) Beats $(0.39) Estimate
Vera Therapeutics (NASDAQ:VERA) reported quarterly losses of $(0.33) per share which beat the analyst consensus estimate of $(0.39) by 15.38 percent. This is a 97.03 percent increase over losses of $(11.10) per share